Impact of generic atorvastatin on Lipitor
in the US
Pfizer has authorized Ranbaxy and US-based Watson Pharmaceuticals with exclusive rights to sell the generic version of Lipitor
for six months in the US.
The pharmaceutical giant devised discounts and incentives for patients, insurers and companies that process Lipitor
prescriptions, and in many cases those moves have made the branded drug about as cheap as or cheaper than much of its generic competition.
According to IMS sales data, annual US sales of Lipitor
were about USD7.
Mackay cited new products including tasocitinib for rheumatoid arthritis as among those that will replace lost revenue from cholesterol-fighting Lipitor
The trial compared the effect of the two dosages on cardiovascular events over a median of almost 5 years in 10,001 patients who had clinically evident heart disease and elevated LDL cholesterol levels, after an 8-week period during which all participants received 10 mg of Lipitor
daily and achieved target LDL cholesterol levels lower than 130 mg/dL.
You don't state what dose of Lipitor
you are taking, but we are now prescribing doses as high as 80 mg a day.
Assess the impact of key patent expiries, such as Pfizer's Lipitor
under which the latter serves as the authorized distributor of the generic version of Lipitor
1 December 2011 - US Watson Pharmaceuticals Inc (NYSE:WPI) said on Wednesday it had launched an authorised generic version of LIPITOR
(atorvastatin calcium tablets) as part of an exclusive deal with Pfizer Inc (NYSE:PFE).
s (Whitehouse Station NJ) application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor
, the world's top-selling drug.
Food and Drug Administration alerted Americans that its British counterpart has recalled a batch of Lipitor
(atorvastatin) because it was found to contain counterfeit tablets.
The cholesterol-lowering medicine Lipitor
helps protect people with diabetes from heart attacks and strokes, according to a large study presented at the recent annual meeting of the American Diabetes Association.
When given to mice, Lipitor
prevented the disease from progressing and reduced paralysis, which can occur in late stages of multiple sclerosis.
A group of cardiac patients across Europe who tested the drug, called Lipitor
, responded so well that scientists think it's almost ready for use.